The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


DACEPTON



EVER Valinject GmbHPA1774/001/001

Main Information

Trade NameDACEPTON
Active SubstancesAPOMORPHINE HYDROCHLORIDE HEMIHYDRATE
Dosage FormSolution for Inj/Inf
Licence HolderEVER Valinject GmbH
Licence NumberPA1774/001/001

Group Information

ATC CodeN04BC07 apomorphine

Status

License statusWithdrawn
Withdrawn Date01/02/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back